OverviewSuggest Edit

Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performances of its process, operates its industrial pilot, has begun the construction of its demo plant in Germany, and prepares the first full-scale plant through a Joint-Venture with Cristal Union, named IBN-One. The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 – ALGBE).
TypePublic
Founded2008
HQÉvry, FR
Websiteglobal-bioenergies.com

Latest Updates

Employees (est.) (Dec 2020)39
Share Price (Jan 2021)€9.5 (+18%)
Cybersecurity ratingBMore

Global Bioenergies Office Locations

Global Bioenergies has an office in Évry
Évry, FR (HQ)
5 Rue Henri Auguste Desbruères
Show all (1)

Global Bioenergies Financials and Metrics

Global Bioenergies Revenue

Market capitalization (15-Jan-2021)

82.6m

Closing stock price (15-Jan-2021)

9.5
Global Bioenergies's current market capitalization is €82.6 m.
Show all financial metrics

Global Bioenergies Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

Global Bioenergies Online and Social Media Presence

Embed Graph

Global Bioenergies News and Updates

Correction: Global Bioenergies Reduces Its Losses

GLOBAL BIOENERGIES REDUCES ITS LOSSES

White Biotechnology Market report highlights the development trends, Factors that are driving the market growth, and key players such as Novozymes, Global Bioenergies, Metabolic Explorer, Amyris

The important factors directing the White Biotechnology market towards outputting huge profits is a thorough learning of the competitive landscape Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Bioenergies receives letters of intent for purchases covering the capacity of its first plant...

Global Bioenergies receives letters of intent for purchases covering the capacity of its first plant project, IBN-One, a joint venture with Cristal Union.

Reminder- Global Bioenergies to Present at Lytham Partners Virtual Investor Conference

             Global Bioenergies to Present at Lytham Partners Virtual Investor ConferenceEvent to take place on Tuesday, October 30, 2018 at 8:30 am Pacific Time / 11:30 am Eastern Time / 4 :30 pm Continental Europe time

Reminder - Global Bioenergies to Present at Lytham Partners Virtual Investor Conference

             Global Bioenergies to Present at Lytham Partners Virtual Investor ConferenceEvent to take place on Tuesday, October 30, 2018 at 8:30 am Pacific Time / 11:30 am Eastern Time / 4 :30 pm Continental Europe time
Show more

Global Bioenergies Blogs

Annual figures and changes to the Board of Directors

Net loss for the Group of €12.7m in 2019, an improvement of €0.9m compared to 2018  Cash position of €16.6 million at 31 December 2019  Ms. Corinne Granger joins the Board of Directors   Evry, 11 March, 2020 – The Board of Directors of Global Bioenergies (Euronext Growth: ALGBE) held today approved …

Global Bioenergies reduces its loss

Evry (France), 17 October 2019 – Publication of half-year financial statements as at 30 June 2019, audited and adopted by the Board of Directors at today’s meeting. The report for the first half of 2019 is available on the Global Bioenergies website, under the heading “Investors/Regulated Informatio…

€3.1 million from ADEME to move forward on the IBN-One plant project

Evry (France), 2 October 2019 Global Bioenergies will soon be receiving €2.6 million and IBN-One €0.5 million in the form of repayable advances, following last July’s achievement of a technical and financial milestone in the ISOPROD project funded by the French Environment and Energy Management Agen…

Half-year report on the liquidity contract as of 28/06/2019

Evry (France) – 26 July 2019 – Global Bioenergies (Alternext Paris: ALGBE) presents the half-year report on the liquidity contract entrusted to the brokerage firm Gilbert Dupont. The following assets appeared on the liquidity account as of 28 June 2019:  – Number of shares: 10,223 shares – Cash bala…

A Shareholders’ Meeting will be held on 5 September 2019

Evry (France), 25 July 2019 – Global Bioenergies has announced that it will hold a shareholder’s meeting on 5 September 2019 at 3pm at its offices located at 5, rue Henri Desbruères in Evry, France. The agenda of this shareholder’s meeting is to amend the Articles of Association in order to create t…

Success of the €17m capital increase

Evry (France), on 26 June 2019 Global Bioenergies (the “Company“) announces today having successfully closed its capital increase, launched on 20 June 2019 and conducted through a public offer without preferential subscription rights and without priority subscription period for shareholders (the “Of…
Show more

Global Bioenergies Frequently Asked Questions

  • When was Global Bioenergies founded?

    Global Bioenergies was founded in 2008.

  • How many employees does Global Bioenergies have?

    Global Bioenergies has 39 employees.

  • Who are Global Bioenergies competitors?

    Competitors of Global Bioenergies include Neova, BIOeCON and ED Biogas.

  • Where is Global Bioenergies headquarters?

    Global Bioenergies headquarters is located at 5 Rue Henri Auguste Desbruères, Évry.

  • Where are Global Bioenergies offices?

    Global Bioenergies has an office in Évry.

  • How many offices does Global Bioenergies have?

    Global Bioenergies has 1 office.